Eric Benevich serves as Executive at NEUROCRINE BIOSCIENCES INC, where they oversee executive responsibilities. Since joining the company, Eric Benevich has executed 76 insider transactions totaling $46.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 31, 2026 involved exercising options for 2,294 shares valued at $0.
Eric Benevich currently holds 52,755 shares of NEUROCRINE BIOSCIENCES INC (NBIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Benevich has been a net seller of NBIX stock. They have purchased $0 and sold $46.4M worth of shares.
Eric Benevich's most recent insider trade was on Jan 31, 2026, when they sold 2,294 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $136.06 |
| Discretionary |
| Jan 31, 2026 | NBIX | $0 | Option Exercise | 2,294 | $N/A | Discretionary |
| Nov 28, 2025 | NBIX | $905.9K | Sale | 5,970 | $151.74 | Discretionary |
| Nov 28, 2025 | NBIX | $214.9K | Option Exercise | 5,970 | $35.99 | Discretionary |
| Apr 15, 2024 | NBIX | $1.7M | Sale | 12,587 | $133.36 | Planned |
| Apr 15, 2024 | NBIX | $589.3K | Option Exercise | 7,231 | $81.49 | Planned |
| Apr 15, 2024 | NBIX | $964.3K | Sale | 7,231 | $133.36 | Planned |
| Apr 15, 2024 | NBIX | $1.0M | Option Exercise | 12,587 | $81.05 | Planned |
| Mar 14, 2024 | NBIX | $9.7M | Sale | 69,521 | $139.38 | Planned |
| Mar 14, 2024 | NBIX | $5.6M | Option Exercise | 69,521 | $81.05 | Planned |
| Mar 14, 2024 | NBIX | $763.7K | Sale | 5,479 | $139.38 | Planned |
| Mar 14, 2024 | NBIX | $433.0K | Option Exercise | 5,479 | $79.02 | Planned |
| Feb 28, 2024 | NBIX | $2.3M | Option Exercise | 53,143 | $43.24 | Planned |
| Feb 28, 2024 | NBIX | $1.7M | Option Exercise | 21,857 | $79.02 | Planned |
| Feb 28, 2024 | NBIX | $2.9M | Sale | 21,857 | $134.69 | Planned |
| Feb 28, 2024 | NBIX | $7.2M | Sale | 53,143 | $134.69 | Planned |
| Feb 13, 2024 | NBIX | $146.0K | Sale | 1,098 | $133.01 | Planned |
| Feb 8, 2024 | NBIX | $131.5K | Sale | 980 | $134.19 | Planned |
| Feb 6, 2024 | NBIX | $181.9K | Sale | 1,280 | $142.12 | Planned |
| Jan 31, 2024 | NBIX | $169.9K | Sale | 1,207 | $140.78 | Planned |
| Aug 21, 2023 | NBIX | $171.8K | Sale | 1,600 | $107.40 | Planned |
| Feb 8, 2023 | NBIX | $102.0K | Sale | 980 | $104.12 | Discretionary |
| Feb 7, 2023 | NBIX | $1.6M | Sale | 15,360 | $102.42 | Discretionary |
| Feb 7, 2023 | NBIX | $207.6K | Sale | 2,030 | $102.29 | Discretionary |
| Feb 6, 2023 | NBIX | $135.2K | Sale | 1,280 | $105.63 | Discretionary |
| Jan 31, 2023 | NBIX | $132.7K | Sale | 1,207 | $109.95 | Discretionary |
| Jan 6, 2023 | NBIX | $50.0K | Sale | 400 | $125.00 | Discretionary |
| Jan 6, 2023 | NBIX | $17.3K | Option Exercise | 400 | $43.24 | Discretionary |
| Nov 30, 2022 | NBIX | $867.5K | Option Exercise | 20,063 | $43.24 | Discretionary |